Gemzar Related Clinical Trials
Gleevec and Gemzar in Patients With Epithelial Ovarian Cancer [Completed]
Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine [Terminated]
Gemcitabine/Clofarabine/Busulfan and Allogeneic Transplantation for Aggressive Lymphomas [Recruiting]
PP-Gemcitabine & External Beam Radiation-Sarcomas [Completed]
A Two-Dimensional Dose-Finding Study of Ixazomib in Combination With Gemcitabine and Doxorubicin, Followed by a Phase II Extension to Assess the Efficacy of This Combination in Metastatic, Surgically Unresectable Urothelial Cancer [Recruiting]
Gemcitabine, Cisplatin, and Abraxane in Advanced Biliary Cancers [Recruiting]
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer [Active, not recruiting]
Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors [Active, not recruiting]
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer [Completed]
A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic Cancer [Completed]
Gemcitabine Pharmacokinetics After Preoperative Chemoradiation Therapy [Active, not recruiting]
Phase II Study of Six Hours Low Dose Gemcitabine Plus Cisplatin in the Treatment for Advanced Pleural Mesothelioma [Active, not recruiting]
Pemetrexed Disodium and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Active, not recruiting]
HAI Abraxane With Gemcitabine and Bevacizumab [Completed]
Gemcitabine and Pulse Dose Erlotinib in Second Line Treatment of Advanced Pancreatic Cancer [Recruiting]
Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas [Terminated]
Safety Study of ABT-263 in Combination With Gemzar (Gemcitabine) in Subjects With Solid Tumors [Completed]
PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine) [Recruiting]
Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer [Active, not recruiting]
A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin [Active, not recruiting]
Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors or Lymphoma [Recruiting]
PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Untreated Pancreatic Cancer [Recruiting]
A Phase I/II Study Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas [Recruiting]
Trial of Simvastatin and Gemcitabine in Pancreatic Cancer Patients [Active, not recruiting]
Gemcitabine Pharmacokinetics [Active, not recruiting]
Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors [Completed]
Abraxane and Gemcitabine Versus Gemcitabine Alone in Locally Advanced Unresectable Pancreatic Cancer. [Active, not recruiting]
Metformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection [Recruiting]
Huachansu & Gemcitabine in Pancreatic Cancer [Completed]
MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer [Active, not recruiting]
Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies [Completed]
Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma [Active, not recruiting]
Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer [Completed]
Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer [Terminated]
Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies [Recruiting]
Phase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic Cancer [Recruiting]
ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors [Completed]
Pemetrexed Plus Gemcitabine in Renal Cell Cancer [Terminated]
Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Patients With Locally Advanced or Metastatic Pancreatic Cancer [Recruiting]
Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine [Recruiting]
GTI-2040 and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors [Completed]
Lag-3 and Gemcitabine for Treatment of Advanced Pancreas Cancer [Terminated]
Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer [Recruiting]
Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer [Completed]
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer [Completed]
Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic Cancer [Completed]
Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung Cancers [Recruiting]
Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies [Completed]
Study of Gemzar®, Taxotere®, and Xeloda® (GTX) in Patients With Metastatic Pancreatic Cancer (Stage IVB) [Completed]
Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma [Recruiting]
Gemcitabine and Dasatinib in Advanced Solid Tumors [Completed]
M402 in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer [Recruiting]
Study of Sorafenib, Gemcitabine, and Cisplatin in Advanced Hepatocellular Carcinoma (HCC) [Withdrawn]
Gamma-Secretase Inhibitor RO4929097 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors [Completed]
Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies [Active, not recruiting]
Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Myeloma [Not yet recruiting]
Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer [Active, not recruiting]
Study of Low-Dose Radiation Therapy to the Whole Liver in Combination With Gemcitabine and Cisplatin in Intrahepatic Cholangiocarcinoma [Recruiting]
Cisplatin and Gemcitabine With or Without Bevacizumab in EGFR Wild-type Non-Small Cell Lung Cancer [Recruiting]
Nab-paclitaxel Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection [Recruiting]
Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer [Completed]
Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients [Completed]
Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma [Active, not recruiting]
Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma [Recruiting]
Gemzar, Cisp, Sunitinib Urothelial Ca [Completed]
A Study of Gemcitabine and Cyberknife Radiation Therapy for Pancreatic Cancer [Completed]
Study of Pre-surgery Gemcitabine + Hydroxychloroquine (GcHc) in Stage IIb or III Adenocarcinoma of the Pancreas [Active, not recruiting]
Dose Escalation Study of Gemcitabine and ON 01910.Na in Solid Tumors [Completed]
Chemoradiation +Gemcitabine +Continuous 5-FU (Fluorouracil) Followed by High Dose Brachytherapy/Stereotactic Radiation Boost in Locally Advanced Intra/Extrahepatic Cholangiocarcinoma [Terminated]
Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy [Active, not recruiting]
Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer [Recruiting]
Allogeneic Stem Cell Transplant for Chronic Lymphocytic Leukemia (CLL) [Recruiting]
Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer [Completed]
A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer [Completed]
CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer [Completed]
Selinexor, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Pancreatic Cancer [Recruiting]
Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor Copanlisib With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer [Active, not recruiting]
Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer [Completed]
Phase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer [Recruiting]
Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma [Completed]
Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural Mesothelioma [Recruiting]
Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma [Active, not recruiting]
Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery [Recruiting]
Study of Gemcitabine and Abraxane for Pancreas Cancer [Recruiting]
Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC [Terminated]
Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid Tumor [Terminated]
Cisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Completed]
Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors [Completed]
The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guerin on the Quality of Life in Superficial Bladder Cancer [Completed]
Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma [Active, not recruiting]
p53MVA Vaccine and Gemcitabine Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer [Recruiting]
A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Cancer [Terminated]
Safety Study of Adjuvant Gemcitabine Started One Week After Laparoscopic Distal Pancreatectomy for Adenocarcinoma [Not yet recruiting]
Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-na�ve Patients With Locally Advanced or Metastatic Urothelial Carcinoma [Completed]
ADH-1, Gemcitabine Hydrochloride and Cisplatin in Treating Patients With Metastatic Pancreatic or Biliary Tract Cancer That Cannot Be Removed By Surgery [Recruiting]
Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer [Recruiting]
|